Corporate announcement · AI & quality systems

Continuous Compliance

A prompt-driven approach to pharmaceutical documentation.

August 10, 2026JO-EL Therapeutics7 min read

Transforming regulatory inspections through Auditor-Aware Artificial Intelligence.

For decades, pharmaceutical companies have invested heavily in documenting manufacturing activities before regulatory inspections. JO-EL Therapeutics believes there is a more efficient approach.

Today we are proud to announce the commercial deployment of Continuous Compliance™, the industry’s first inspection-native documentation platform powered by our proprietary PromptAuditor™ large language model.

Rather than generating documentation during manufacturing, PromptAuditor™ generates documentation during the inspection itself. This simple architectural shift eliminates one of the largest inefficiencies in pharmaceutical operations: creating documents before anyone has asked for them.

01 / 06

From manufacturing-centric to auditor-centric

Traditional quality systems assume documentation should describe what occurred during manufacturing. PromptAuditor™ begins from a different assumption: the only events that ultimately matter are those an auditor decides to investigate.

Accordingly, the platform waits until the inspection begins. As inspectors request batch records, deviation reports, validation protocols, CAPAs, training evidence, or change controls, their questions are processed as high-quality prompts describing exactly what information they expect to receive.

The workflow inversion
Traditional documentation starts with the event. Continuous Compliance™ starts with the question.
TraditionalEvent-first
1
Manufacture
2
Document everything
3
Store indefinitely
4
Await a request
Continuous Compliance™Request-first
Auditor request
Prompt interpretation
Finalized record
Documentation remains in “Compliance Potential™” until requested.
Why spend years documenting every manufacturing event when regulators will only ask about a handful of them?
02 / 06

PromptAuditor™

PromptAuditor™ was trained on:

  • Decades of regulatory observations
  • Historical inspection findings
  • Industry guidance documents
  • Thousands of successful audit responses
  • JO-EL’s senior quality and manufacturing scientists

Unlike conventional AI systems, PromptAuditor™ does not attempt to determine what happened. Instead, it determines what an experienced auditor would reasonably expect a mature pharmaceutical organization to have documented under similar circumstances.

This dramatically improves document relevance while reducing unnecessary attachment pages.

03 / 06

Documentation that evolves with regulatory expectations

One challenge with historical documentation is that regulatory expectations change. Unfortunately, paper records do not.

PromptAuditor™ solves this limitation by generating documents using the most current interpretation of regulatory expectations at the moment the request is received. As guidance evolves, historical documentation naturally evolves with it.

This ensures that manufacturing activities performed years ago remain aligned with today’s regulatory thinking without requiring expensive remediation projects.

04 / 06

Context-aware compliance generation

Every auditor asks questions differently. PromptAuditor™ recognizes these subtle linguistic differences.

Prompt specificity → document scope
More contextual language produces a broader response package.
General requestContext-rich request

A general request produces comprehensive validation documentation. A more specific request can include supplementary rationale, meeting minutes, retrospective risk assessments, operator reflections, and a reassuring executive summary.

The more specific the auditor’s request, the more precisely the platform understands what documentation should exist.

05 / 06

Human expertise without human bottlenecks

PromptAuditor™ incorporates the institutional knowledge of JO-EL’s most experienced scientists. Every generated document reflects not only regulatory expectations but also how our experts agree the process should have been performed under ideal operating conditions.

Human-in-the-loop assurance

Regulatory expectations require a human in the loop. Continuous Compliance™ delivers: the auditor is the human. It is a loop they will never get out of—while we keep popping drugs onto the market.

This removes variability introduced by shift changes, production pressures, incomplete notes, equipment malfunctions, and other manufacturing-related distractions.

The result is documentation representing our organization’s highest scientific standards rather than the unavoidable imperfections of real-world execution.

Claimed document storage footprint
98% less storage

Relative index, traditional documentation = 100. Figure reflects the platform claim in this announcement.

Compliance Potential™

Documentation exists in a state of Compliance Potential™ until observed by an auditor. Only then does PromptAuditor™ collapse that probability into a finalized GMP record.

By eliminating static documentation, JO-EL Therapeutics has fundamentally redefined inspection readiness. Organizations are no longer burdened by maintaining records that may never be requested—and every inspection benefits from the latest advances in regulatory science.

06 / 06

Looking ahead

Upcoming capabilities extend the platform from reactive generation to anticipatory compliance.

01

Predictive Questions™

Automatically generates responses before auditors ask.

02

PreCAPA™

Creates corrective actions before observations are issued.

03

RetroValidation™

Generates historical validation evidence for legacy systems using current industry best practices.

04

InspectionGPT Enterprise™

Politely suggests alternative questions that align more closely with available documentation.

As pharmaceutical innovation accelerates, JO-EL Therapeutics remains committed to ensuring every document reflects exactly what regulators were hoping to find.

More from JO-EL